Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented ...
dvm360

Ready-to-use feline OA stem cell therapy gains entry to FDA’s faster conditional approval pathway

A stem cell therapy with potential disease-modifying effects for feline osteoarthritis (OA) is underway.

Reju Stem Cells Marks Four-Year Anniversary with Focus on Clinical Transparency and the Science of Healthspan Expansion

Reju Stem Cells celebrates four years of growth, advancing regenerative medicine with a focus on transparency, patient ...

Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)

Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral ...

Mesoblast Secures CAR Platform to Sharpen Targeting of Cell Therapies

Detailed price information for Mesoblast Ltd Ord (MEOBF) from The Globe and Mail including charting and trades.
Medindia on MSN

Menstrual blood: The future of osteoarthritis therapy

India, April 14 -- Can tissue degradation be reversed in osteoarthritis?
Popular Mechanics

Scientists Built Working Hair Follicles in a Lab. They Could Cure Baldness Forever.

Treating hair loss is a multi-billion dollar business, so scientists (and many others) are interested in understanding how to generate functioning hair follicles in the lab. A new study found that ...